ClinicalTrials.Veeva

Menu

Kidney Disease After COVID-19

Mount Sinai Health System logo

Mount Sinai Health System

Status

Completed

Conditions

COVID-19
Acute Kidney Injury
Chronic Kidney Injury

Study type

Observational

Funder types

Other

Identifiers

NCT05328986
1300143 (Other Identifier)
STUDY-20-01326

Details and patient eligibility

About

To understand the long-term epidemiology, develop effective risk-prediction and stratification tools, and understand the pathobiology of kidney disease in COVID-19 survivors.

Enrollment

1,753 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Criteria:

Inclusion Criteria:

  • Adults, age ≥18 years
  • Confirmed diagnosis of COVID-19

Exclusion Criteria:

• No confirmed diagnosis of COVID-19

Trial design

1,753 participants in 1 patient group

COVID
Description:
Patients who have had a confirmed diagnosis of COVID-19.

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems